Search

Search Constraints

You searched for: Author/Creator Pavel, A.B.

Search Results

1. ASN002 demonstrates efficacy and improves inflammation in AD. (1st October 2019)

2. ASN002 证明有疗效并可改善AD 炎症. (1st October 2019)

3. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing. (15th June 2020)

4. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing. (1st December 2020)

7. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (6th May 2019)

8. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (1st October 2019)